000			01949nam a2200361 a 4500
003			EG-GiCUC
005			20250223025917.0
008			090819s2009 ua d f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.08.08.M.Sc.2009.Ta.P
100	0		_aTayseer Mohamed Abdelrazek Elnawawy
245	1	2	_aA pharmaceutical study on formulation of an antihypertensive drug in controlled release systems / _cTayseer Mohamed Abdelrazek Elnawawy ; Supervised Samia Abdelkader Nour , Dalia M. Ghorab , Abdelmonaem Swailam
246	1	5	_aدراسة صيدلية على صياغة احد عقاقير ضغط الدم المرتفع على هيئة انظمة ممتدة المفعول
260			_aCairo : _bTayseer Mohamed Abdelrazek Elnawawy , _c2009
300			_a147 P. : _bcharts ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
520			_aFormulation of gastroretentive dosage forms is a step toward improving the bioavailability of the drug tested. In order to control its release, diltiazem hydrochloride (highly soluble drug) was formulated as effervescent floating granules prepared using different polymers like eudragit S100, L100, RS100,RL100, in D/P ratio 1:3, 1:5 and 1:7, Also 1:1 1:3, 1:5 and 1:7 were the D/P ratios used for granules prepared using ethylcellulose and lipophilic matrices as: beeswax and carnauba wax
530			_aIssued also as CD
653		4	_aDiltiazem hydrochloride
653		4	_aEffervescent floating granules
653		4	_aGastroretentive dosage forms
700	0		_aAbdelmonaem Swailam , _eSupervisor
700	0		_aDalia Mahmoud Ghorab , _eSupervisor
700	0		_aSamia Abdelkader Nour , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
902			_a1
905			_aMustafa _eRevisor
905			_aSamia _eCataloger
942			_2ddc _cTH
999			_c23365 _d23365